Trials / Recruiting
RecruitingNCT06560424
Cardiovascular and Metabolic Sciences Biorepository
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the Cardiovascular and Metabolic Sciences Biorepository is to collect and store information and biospecimens (blood, urine, stool, and heart tissue) from patients with and without cardiovascular and metabolic diseases to create a readily available biorepository of samples and related medical health information to expedite future research into the causes and consequences of cardiovascular and metabolic diseases.
Detailed description
Heart disease is the leading cause of death in the United States and other vascular diseases, like stroke, and metabolic diseases, like diabetes, are consistently in the top ten causes of death (CDC, 2024). There is clearly a need for continuing research and innovation into improved diagnosis and treatment of these diseases. The goal of this biorepository is to provide an easily accessible collection of samples for researchers to utilize. The biorepository will also serve as a place to store residual samples from other cardiovascular disease (CVD) studies for future use, to make the best use of these biospecimen resources.
Conditions
Timeline
- Start date
- 2024-09-18
- Primary completion
- 2050-12-31
- Completion
- 2050-12-31
- First posted
- 2024-08-19
- Last updated
- 2025-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06560424. Inclusion in this directory is not an endorsement.